Summary
Ninety-two patients with bronchogenic carcinoma who were treated by surgical resection of the tumour were subsequently given immunotherapy with BCG (Glaxo). The study was strictly randomised into three groups. Twenty-nine patients received multipuncture BCG (50–250×106 viable units) and 26 patients intradermal BCG (0.4–0.9×106 viable units) treatment being given at 1, 2, 5, 9, 13 and 26 weeks after operation and every 26 weeks thereafter. Thirty-seven control patients did not receive BCG. The patients have been observed for 15–33 months. There was no significant difference in survival between the control group and the two immunotherapy groups or between the two immunotherapy groups. The tumour cell type and presence of mediastinal nodes significantly influenced overall survival but not the response to BCG immunotherapy. The possible reasons for the failure of BCG to prolong survival in this study are discussed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Baldwin, R. W., Pimm, M. V.: Influence of BCG injection on growth of 3 methylcholanthrene induced rat sarcomas. Eur. J. Clin. Biol. Res. 16, 875 (1971)
Barkas, T., Al-Khateeb, S. F., Irvine, W. J., Davidson, N. McD., Roscoe, P.: Inhibition of antibody dependent cell mediated cytotoxicity as a means of detection of immune complexes in the sera of patients with thyroid disorders and bronchogenic carcinoma. Clin. Exp. Immunol. 25, 270 (1976)
Barnes, E. W., Farmer, A., Penhale, W. J., Irvine, W. J., Roscoe, P., Horne, N. W.: Phytohaemagglutin-induced lymphocyte transformation in newly presenting patients with primary carcinoma of the lung. Cancer 36, 187 (1975)
Bluming, A. Z., Vogal, C. L., Ziegler, J. L., Mody, N., Kamya, G. L.: Immunological effects of BCG in malignant melanoma: Two modes of administration compared. Ann. Int. Med. 76, 405 (1972)
Chee, D. O., Bodurtha, A. J.: Facilitation and inhibition of B16 melanoma by BCG in vivo and by lymphoid cells from BCG-treated mice in vitro. Int. J. Cancer 14, 137 (1974)
Crofton, J. W., Douglas, A. C.: In: Respiratory Diseases, 2nd ed., p. 583. London: Blackwell 1975
Donaldson, R. C.: Methotrexate plus Bacille Calmette-Guerin (BCG) and isoniazid in the treatment of cancer of the head and neck. Am. J. Surg. 124, 527 (1972)
Edwards, F. R., Whitwell, F.: Use of BCG as an immunostimulant in the surgical treatment of carcinoma of the lung. Thorax 29, 654 (1974)
Gehan, E. A.: A generalised Wilcoxon test for comparing arbitrarily singly censored samples. Biometrika 52, 203 (1965)
Grant, R. M., Mackie, R., Cochrane, A. J., Murray, E. L., Hoyle, D., Ross, C.: Results of administering BCG to patients with melanoma. Lancet 2, 1096 (1974)
Gutterman, J. U., Mavligh, G., Gottlieb, J. A., Burgess M. A., McBride, C. E., Einhorn, L., Freireich, E. J., Hersh, E. M.: Chemotherapy of disseminated malignant melanoma with dimethyltriazeno imadazole carboxamine and Bacillus Calmette-Guerin. New Engl. J. Med. 291, 592 (1974)
Israel, L.: Preliminary results of non-specific immunotherapy for lung cancer. Cancer Chemotherapy Reports 4, 283 (1973)
McKneally, M. F., Maver, C., Kausel, H. W.: Regional immunotherapy of lung cancer with intrapleural BCG. Lancet 1, 593 (1977)
Mathé, G.: Surviving in company of BCG. Cancer Immunology and Immunotherapy 1, 3 (1976)
Mathé, G., Amiel, J. L., Schwartzenberg, L., Schneider, M., Cattan, A., Schlumberger, J. R., Hayat, M., de Vassal, F.: Active immunotherapy for acute lymphoblastic leukaemia. Lancet 1, 697 (1969)
Muggleton, P. W., Hilton, M. L.: Personal communication
Pinksy, C., Hirhaut, Y., Oettgen, H.: Treatment of malignant melanoma by intratumoral injection of BCG. Proc. Am. Assoc. Cancer Res. 13, 21 (1972)
Ruckdeschel, J. C., Codish, S. D., Stranahan, A., McKneally, M. P.: Postoperative empyema improves survival in lung cancer. New Engl. J. Med. 287, 1013 (1972)
Sparks, F. C., Silverstein, M. J., Hunt, J. S., Haskell, C. M., Pilch, Y. H., Morton, D. L.: Complications of BCG immunotherapy in patients with cancer. New Engl. J. Med. 289, 827 (1973)
Zbar, B., Rapp, H. J., Ribi, E. E.: Tumour suppression by cell walls of mycobacterium bovis attached to oil droplets. J. Natl. Cancer Inst. 48, 831 (1972)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Roscoe, P., Pearce, S., Ludgate, S. et al. A controlled trial of BCG immunotherapy in bronchogenic carcinoma treated by surgical resection. Cancer Immunol Immunother 3, 115–118 (1977). https://doi.org/10.1007/BF00200068
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00200068